Literature DB >> 9607021

Protection against measles virus-induced encephalitis by antibodies from mice immunized intranasally with a synthetic peptide immunogen.

L J Hathaway1, O E Obeid, M W Steward.   

Abstract

Balb/c mice were immunized intranasally (i.n.) with a chimeric synthetic peptide containing two copies of a T- and one copy of a B-cell epitope (TTB) from measles virus (MV) fusion protein, plus cholera toxin B (CTB) adjuvant. The antibodies induced cross-reacted with, and neutralized MV and on passive transfer, protected mice against encephalitis induced by neuroadapated MV. Immunization with TTB alone induced antibodies which increased survival but not significantly compared to controls. Furthermore, i.n. immunization with TTB plus CTB induced TTB-specific IgA antibodies in saliva and nasal washes. Co-administration of CTB increased the affinity of antibodies to the B-cell epitope of TTB and caused a relative increase in the level of anti-peptide antibodies of the IgG2a subclass and the overall titre of IgG antibodies. These results indicate the potential of the i.n. route for immunization with synthetic peptide immunogens for induction of both local and systemic anti-peptide antibody responses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9607021     DOI: 10.1016/s0264-410x(97)88326-0

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Targeting of nasal mucosa-associated antigen-presenting cells in vivo with an outer membrane protein A derived from Klebsiella pneumoniae.

Authors:  L Goetsch; A Gonzalez; H Plotnicky-Gilquin; J F Haeuw; J P Aubry; A Beck; J Y Bonnefoy; N Corvaïa
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

2.  Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses.

Authors:  Lbachir BenMohamed; Radhika Krishnan; Catherine Auge; James F Primus; Don J Diamond
Journal:  Immunology       Date:  2002-05       Impact factor: 7.397

3.  Facilitated intranasal induction of mucosal and systemic immunity to mutans streptococcal glucosyltransferase peptide vaccines.

Authors:  D J Smith; W F King; L A Barnes; D Trantolo; D L Wise; M A Taubman
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Purification, characterization and in vitro and in vivo immune enhancement of polysaccharides from mulberry leaves.

Authors:  Xiaolan Chen; Zhicun Sheng; Shulei Qiu; Haifeng Yang; Jiping Jia; Jing Wang; Chunmao Jiang
Journal:  PLoS One       Date:  2019-01-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.